Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil
Status:
Completed
Trial end date:
2017-10-10
Target enrollment:
Participant gender:
Summary
A randomized, open label, single dose, two-way crossover clinical trial to investigate the
pharmacokinetics and safety/tolerability of YY-201 in comparison to Dutasteride and Tadalafil
administered in healthy male volunteers